Teladoc (TDOC), GoodRx shares drop after OpenAI health feature launch

Shares of Teladoc (TDOC) and GoodRx declined following the launch of a new health feature by OpenAI. This development has generated concern among investors about the potential impact on both companies' market positions. The exact percentage of the drop in share prices was not specified. The launch of AI-powered health tools by OpenAI could intensify competition in the telehealth sector, prompting investors to reassess the future profitability of Teladoc and GoodRx. Investors should monitor these developments as they may affect the performance of TDOC and GoodRx.